Table 3 |
|||
|
Multivariate analysis of factors related to severe thrombocytopenia |
|||
|
Multivariate Analysis |
|||
|
|
|||
|
Factors |
P value |
Odds Ratio |
95% Confidence Interval |
|
|
|||
|
BMI (< 24.5/≥ 24.5 Kg/m2) |
0.280 |
||
|
ALB (≤ 4.1/> 4.1 g/dL) |
0.412 |
||
|
ALK-p (≥ 97/< 97 U/L) |
0.646 |
||
|
PLT (< 100,000/≥ 100,000/μL) |
< 0.001 |
179.219 |
12.219-2628.602 |
|
HCV-RNA (log10, IU/mL) (≥ 5.95/< 5.95) |
0.196 |
||
|
HCV genotype (1/2) |
0.419 |
||
|
Ribavirin dose (≤ 24.58/> 24.58) |
0.201 |
||
|
Rate of PLT decline at week 2 (early PLT decline, > 30%/≤ 30%) |
0.003 |
45.742 |
3.524-593.689 |
|
|
|||
|
Abbreviations: ALB: albumin; ALK-p: alkaline phosphatase; AST: aspartate aminotransferase; PLT: platelet; BMI: body mass index; C.I.: confidence interval; HCV: hepatitic C virus. |
|||
|
Lin et al. BMC Gastroenterology 2012 12:7 doi:10.1186/1471-230X-12-7 |
|||
